A new drug for patients who have a hard time controlling their asthma could be nearing an FDA review. Tarrytown, NY-based Regeneron Pharmaceuticals (NASDAQ: REGN) and partner Sanofi this morning are touting results this morning from a 1,902-patient Phase 3 study called Liberty Asthma Quest. In it, their injectable antibody drug dupilumab (Dupixent), already approved […]
NYS Entity Status
NYS Filing Date
JANUARY 30, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - CLARE RICHARDSON USA LLC
Around the Web
- Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing
By Ben Fidler - Monday Sep 11, 2017
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- On the Runway: A First Look at the New Givenchy
By VANESSA FRIEDMAN - Monday Jul 10, 2017
Men and women achieve full equality under Clare Waight Keller, the house’s first female artistic director — and there are other surprises.
- Reinventing Givenchy
By VANESSA FRIEDMAN - Tuesday Sep 26, 2017
Clare Waight Keller, the house’s first female artistic director, has a lot riding on her debut show Sunday.
- Sheldon Richardson’s fury will make Jets-Giants interesting
By Mark Cannizzaro - Monday Jul 31, 2017
The Sheldon Richardson-Brandon Marshall Jets feud from the 2016 season will not go away, because we will not let it go away. Richardson, the Jets defensive lineman who fought with Marshall, now with the Giants, on a number of occasions last year, was asked on Sunday about comments Marshall recently made about being glad he...